Oliver Smart is now with Global Phasing and HOLE is supported
by/available from the Sansom lab at Oxford:
http://hole.biop.ox.ac.uk/hole
Quoting "Hargreaves, David" <david.hargrea...@astrazeneca.com>:
Dear CCP4,
I'm looking for the authors of the programs (listed below). I want to
analyse our crystal systems and would like to use these algorithms.
However, I'm not convinced the addresses on the papers are current.
Does anybody know how to contact the authors or of any other programs
that exist for these calculations?
Is there anything in the CCP4 arsenal for this purpose?
I'm happy to be contacted directly.
Thanks,
Dave
"HOLE: A program for the analysis of the pore dimensions of ion channel
structural models"
Oliver S. Smart, Joseph G. Neduvelil, Xiaonan Wang, B. A. Wallace, Mark
S. P. Sansomt
J. Mol. Graphics, 1996, vol14
"An algorithm to find channels and cavities within protein crystals
(CHANNEL)": Oleg S. Kisljuk, Galina S. Kachalova and Nadejda Ph. Lanina
J. Mol. Graphics, 1994, vol12
David Hargreaves
Associate Principal Scientist
_____________________________________________________________________
AstraZeneca
DECS, CP&SS
Mereside, 50F49, Alderley Park, Cheshire, SK10 4TF
Tel +44 (0)01625 518521 Fax +44 (0) 1625 232693
David.Hargreaves @astrazeneca.com <mailto:name.surn...@astrazeneca.com>
Please consider the environment before printing this e-mail
--------------------------------------------------------------------------
AstraZeneca UK Limited is a company incorporated in England and
Wales with registered number: 03674842 and a registered office at 2
Kingdom Street, London, W2 6BD.
Confidentiality Notice: This message is private and may contain
confidential, proprietary and legally privileged information. If you
have received this message in error, please notify us and remove it
from your system and note that you must not copy, distribute or take
any action in reliance on it. Any unauthorised use or disclosure of
the contents of this message is not permitted and may be unlawful.
Disclaimer: Email messages may be subject to delays, interception,
non-delivery and unauthorised alterations. Therefore, information
expressed in this message is not given or endorsed by AstraZeneca UK
Limited unless otherwise notified by an authorised representative
independent of this message. No contractual relationship is created
by this message by any person unless specifically indicated by
agreement in writing other than email.
Monitoring: AstraZeneca UK Limited may monitor email traffic data
and content for the purposes of the prevention and detection of
crime, ensuring the security of our computer systems and checking
Compliance with our Code of Conduct and Policies.
----------------------------------------------------------------
This message was sent using IMP, the Internet Messaging Program.
